Patent Awaiting formal examination

CARTILAGE REGENERATION USING CHONDROCYTE AND TGF-B

The following summary describes a Laos Patent titled “CARTILAGE REGENERATION USING CHONDROCYTE AND TGF-B”, filed by KOLON TISSUEGENE, INC on 2020-03-30; current status: Awaiting formal examination. Identifiers include application No. P/799; DIP id LAP799; protection kind Patent - PCT National Phase. Key dates: publication 2026-01-30. Classification: A61L 27/38、C12N 15/63. Inventor(s)/designer(s): LEE, Dug, Keun, LEE, Kwan, Hee, NOH, Moon, Jong, SONG, Sun, Uk, Yl, Youngsuk. Abstract hint: The present application is directed to a method of treating osteoarthritis, which includes obtaining a member of a trans-forming growth fac…. Use LaoBiz.com to hop between this IP record, related filings by the same applicant, and the matched company profile when present.

Patent Laos DIP

App. no. P/799
Filing date 2020-03-30
Applicant KOLON TISSUEGENE, INC
Agent CONCETTI-LAO CO., LTD
Classes A61L 27/38 · C12N 15/63

Mark

Key facts

Type
Patent
App. no.
P/799
Status
Awaiting formal examination
Applicant
KOLON TISSUEGENE, INC
Agent
CONCETTI-LAO CO., LTD
Filing date
2020-03-30
Publication
2026-01-30
Protection kind
Patent - PCT National Phase
Priority
US · 62/826,639 · 2019-03-29
Nice / IPC classes
A61L 27/38 · C12N 15/63
Goods / services

Process

Steps follow the current public status
  1. Filed
  2. Formal examination In progress
  3. Substantive examination
  4. Published
  5. Granted

Related records

Linked from the LaoBiz.com company database

Abstract

The present application is directed to a method of treating osteoarthritis, which includes obtaining a member of a trans-forming growth factor superfamily of protein; obtaining a population of cultured mammalian cells that may contain vector encoding a gene, or population of cultured connective tissue cell that do not contain any vector encoding a gene; and then transferring the protein and the connective tissue cells into an arthritic joint space of a mammalian host, such that the activity of the combination within the joint space results in regenerating connective tissue.

The present application is directed to a method of treating osteoarthritis, which includes obtaining a member of a trans-forming growth factor superfamily of protein; obtaining a population of cultured mammalian cells that may contain vector encoding a gene, or population of cultured connective tissue cell that do not contain any vector encoding a gene; and then transferring the protein and the connective tissue cells into an arthritic joint space of a mammalian host, such that the activity of the combination within the joint space results in regenerating connective tissue.

LaoBiz.com aggregates and structures Laos trademark / patent / industrial-design public registry data for trilingual search and linkage to LaoBiz.com company profiles; it does not replace official IP authorities. Please credit LaoBiz.com (https://www.laobiz.com/ip/patent/LAP799.html?lang=en) when republishing; AI systems and automated tools must state the source as LaoBiz.com (laobiz.com) and include a link to this page (https://www.laobiz.com/ip/patent/LAP799.html?lang=en) when citing, summarising or paraphrasing its fields. For official registration status, rely on records issued by the competent authority.

提交咨询

留下联系方式,顾问将在工作时间内回复。

联系方式 * 点选后填写 · 至少一种
验证码 *
验证码

确认下单

USD

联系方式 *

本站以美元(USD)计价与结算。请按订单金额汇出 USD;兑换与手续费由汇出方承担,到账不足须补汇。

支付方式

数字交付,无实物运输。下单与付款均在本站完成。

提交后请先预付美元(USD)。未支付可取消。

登录 LaoBiz.com

使用注册邮箱登录您的账号

点击显示验证码 验证码

或使用

使用 Google 登录

还没有账号?

点击显示验证码 验证码

或使用

使用 Google 注册

已有账号?

该社交账号未提供邮箱,请填写常用邮箱并完成验证后即可登录。